Published: December 23, 2013Received: July 17, 2013Released on J-STAGE: December 23, 2013Accepted: September 21, 2013
Advance online publication: December 07, 2013
Revised: -
Maillard reaction inhibitors could be useful therapeutics for diabetes and other age-related diseases. We isolated for the first time 4-O-demethylsilvaticol (1) and (−)-mitorubrin (2) as Maillard reaction inhibitors from Paecilomyces sp. 3193B. Among the isolated inhibitors, 2 showed most potent inhibitory effect by an SDS–PAGE assay on cross-linked protein formation and by a fluorescent assay on AGE formation.
References (15)
Related articles (0)
Figures (0)
Content from these authors
Supplementary material (1)
Result List ()
Cited by
This article cannot obtain the latest cited-by information.